Bullous pemphigoid responding to sulfapyridine and the sulfones.
about
Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in DermatologyBlistering disorders: diagnosis and treatmentGuidelines for the management of bullous pemphigoidThe IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsoneMucocutaneous disorders.Dapsone.The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patientsTherapy of autoimmune bullous diseasesThe use of i.v. IG therapy in dermatology.Dapsone therapy for the acute inflammatory phase of ocular pemphigoidSulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.Clinical variants of pemphigoid.The treatment of pemphigus and pemphigoid.IgA bullous pemphigoid: a distinct blistering disorder. Case report and review of the literature.Sulfonamides and sulfones in dermatologic therapy.Benign mucous membrane pemphigoid with advanced periodontal involvement: diagnosis and therapy.Management of the immunobullous disorders. I. Pemphigoid.A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.Epidermolysis bullosa acquisita--a sign of cicatricial pemphigoid?Periodontal implications: mucocutaneous disorders.Dapsone as first line therapy for bullous pemphigoid.
P2860
Q28069143-39149B8A-F71C-4A2B-8287-6C7A3980D019Q28205009-EF818C9D-75F2-401A-82F9-4CC1E30A79E9Q28217521-9CEA01A2-699C-4B3E-9153-DD0E2327DE1EQ28365425-4BE89F20-D881-4304-BC7D-C3C90D8CC42CQ33592379-CC0688D4-E163-4461-9AB3-AE6A51E50CB7Q34053226-BD84D62E-5486-4AD4-8F1C-72E48DE2593DQ34403177-88E14480-08A4-4875-8626-7DB94EF7AE19Q35919150-31346F94-8AEE-4E6B-A66C-D348256781A9Q36986054-4F224DE9-0732-4C82-8C65-EA057E359EB7Q37297613-4148EC95-9E74-41C3-8CAC-51F608C4EA42Q37321480-54074437-FB99-47C8-BDF9-CC57EACB9E34Q39728144-8110673A-4467-46C8-8314-C4FAF7B940D2Q40250587-84A44D3A-9201-487F-8DCE-8431650F11E5Q40292578-30C742C8-0A04-4E1D-A3A5-76799559AC00Q40303501-34C942B7-0D95-47A0-8E75-7346B07A4B8AQ40368211-1C998590-D3A6-4B42-B2ED-E423E15D2767Q40480334-D5673E46-9679-42DB-BF88-FD05FB05BE5BQ40551161-479D2BDF-A21A-4F74-97FE-BB714F6B9241Q40785532-F47C9C97-F89D-45BB-94E7-8BBC090988C8Q41129362-9A589213-409C-4DFE-86D9-73E6195B100DQ41444884-F9F7758C-D73F-4224-9775-DE0C0A0C4D42Q54116075-ED93E3D4-638C-4861-9A11-2652829192B6
P2860
Bullous pemphigoid responding to sulfapyridine and the sulfones.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Bullous pemphigoid responding to sulfapyridine and the sulfones.
@en
type
label
Bullous pemphigoid responding to sulfapyridine and the sulfones.
@en
prefLabel
Bullous pemphigoid responding to sulfapyridine and the sulfones.
@en
P1433
P1476
Bullous pemphigoid responding to sulfapyridine and the sulfones.
@en
P2093
Rogers RS 3rd
P304
P356
10.1001/ARCHDERM.113.5.610
P577
1977-05-01T00:00:00Z